| Therapeutic targeting of angiogenesis molecular pathways in angiogenesis-dependent diseases A Fallah, A Sadeghinia, H Kahroba, A Samadi, HR Heidari, B Bradaran, ... Biomedicine & Pharmacotherapy 110, 775-785, 2019 | 214 | 2019 |
| Exosomes: from carcinogenesis and metastasis to diagnosis and treatment of gastric cancer H Kahroba, MS Hejazi, N Samadi Cellular and Molecular Life Sciences 76, 1747-1758, 2019 | 128 | 2019 |
| Tumor-derived exosomes: Implication in angiogenesis and antiangiogenesis cancer therapy. PK Cynthia Aslan, Sepideh Maralbashi, Farhad Salari, Houman Kahroba, Faraz ... Journal of Cellular Physiology, 2019 | 114 | 2019 |
| The role of Nrf2 in neural stem/progenitors cells: From maintaining stemness and self-renewal to promoting differentiation capability and facilitating therapeutic application … H Kahroba, B Ramezani, H Maadi, MR Sadeghi, H Jaberie, F Ramezani Ageing research reviews 65, 101211, 2021 | 89 | 2021 |
| The Role of Nrf2 signaling in cancer stem cells: From stemness and self-renewal to tumorigenesis and chemoresistance H Kahroba, M Shirmohamadi, MS Hejazi, N Samadi Life sciences 239, 116986, 2019 | 75 | 2019 |
| The first report of peste des petits ruminants (PPR) in camels (Camelus dromedarius) in Iran A Zakian, M Nouri, H Kahroba, B Mohammadian, MR Mokhber-Dezfouli Tropical animal health and production 48, 1215-1219, 2016 | 71 | 2016 |
| Clinical application of immune checkpoints in targeted immunotherapy of prostate cancer S Jafari, O Molavi, H Kahroba, MS Hejazi, N Maleki-Dizaji, S Barghi, ... Cellular and Molecular Life Sciences 77, 3693-3710, 2020 | 54 | 2020 |
| Layered double hydroxide nanoparticles as an appealing nanoparticle in gene/plasmid and drug delivery system in C2C12 myoblast cells P Yazdani, E Mansouri, S Eyvazi, V Yousefi, H Kahroba, MS Hejazi, ... Artificial cells, nanomedicine, and biotechnology 47 (1), 436-442, 2019 | 52 | 2019 |
| Potential roles and prognostic significance of exosomes in cancer drug resistance M Mostafazadeh, N Samadi, H Kahroba, B Baradaran, S Haiaty, M Nouri Cell & Bioscience 11 (1), 1, 2021 | 48 | 2021 |
| The oncogenic roles of bacterial infections in development of cancer VT Shirin Eyvazi, Mehdi Asghari Vostakolaei, Azita Dilmaghani, Omid ... Microbial Pathogenesis, 2020 | 47 | 2020 |
| A human chorionic gonadotropin (hCG) delivery platform using engineered uterine exosomes to improve endometrial receptivity H Hajipour, L Farzadi, L Roshangar, Z Latifi, H Kahroba, V Shahnazi, ... Life Sciences 275, 119351, 2021 | 44 | 2021 |
| Altered Th17/Treg ratio as a possible mechanism in pathogenesis of idiopathic membranous nephropathy R Motavalli, J Etemadi, MS Soltani-Zangbar, MR Ardalan, H Kahroba, ... Cytokine 141, 155452, 2021 | 40 | 2021 |
| DNA damage repair response in mesenchymal stromal cells: From cellular senescence and aging to apoptosis and differentiation ability H Kahroba, H Sadeghzadeh, DM Wilson III, H Maadi, N Samadi, ... Ageing research reviews 62, 101125, 2020 | 40 | 2020 |
| Docosahexaenoic acid (DHA) inhibits pro-angiogenic effects of breast cancer cells via down-regulating cellular and exosomal expression of angiogenic genes and microRNAs C Aslan, S Maralbashi, H Kahroba, M Asadi, MS Soltani-Zangbar, ... Life Sciences 258, 118094, 2020 | 39 | 2020 |
| Exosomal Nrf2: From anti-oxidant and anti-inflammation response to wound healing and tissue regeneration in aged-related diseases H Kahroba, Y Davatgaran-Taghipour Biochimie 171, 103-109, 2020 | 37 | 2020 |
| Fundamental insights into the interaction between telomerase/TERT and intracellular signaling pathways S Ghareghomi, S Ahmadian, N Zarghami, H Kahroba Biochimie 181, 12-24, 2021 | 36 | 2021 |
| Role of Nrf2 and mitochondria in cancer stem cells; in carcinogenesis, tumor progression, and chemoresistance Z Payandeh, AP Tazehkand, G Barati, F Pouremamali, H Kahroba, ... Biochimie 179, 32-45, 2020 | 34 | 2020 |
| Corneal endothelium tissue engineering: An evolution of signaling molecules, cells, and scaffolds toward 3D bioprinting and cell sheets M Khalili, M Asadi, H Kahroba, MR Soleyman, H Andre, E Alizadeh Journal of Cellular Physiology, 2020 | 32 | 2020 |
| CDK9 as an appealing target for therapeutic interventions S Eyvazi, MS Hejazi, H Kahroba, M Abasi, RE Zamiri, V Tarhriz Current Drug Targets 20 (4), 453-464, 2019 | 31 | 2019 |
| Arginyl-glycyl-aspartic acid (RGD) containing nanostructured lipid carrier co-loaded with doxorubicin and sildenafil citrate enhanced anti-cancer effects and overcomes drug … RAT Hamed Hajipour, Marjan Ghorbani, Houman Kahroba, Farideh Mahmoodzade ... Process Biochemistry, 2019 | 30 | 2019 |
